Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 115-122

  O'Neill, Michael J ^a   Hicks, Caroline ^a   Ward, Mark ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

7 Nitroindazole; Cerebral ischemia; Hippocampus; Mongolian gerbil; Nitric oxide (NO)

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 7 NITROINDAZOLE; DIZOCILPINE; ELIPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; GERBIL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030605974     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00387-1     Document Type: Article

References (46)

1. Babbedge, R.C., P.A. Bland-Ward, S.L. Hart and P.K. Moore, 1993, Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles, Br. J. Pharmacol. 110, 225.
2. Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall and B.A. Freeman, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA 87, 6120.
3. Borgerding, R.A. and S. Murphy, 1995, Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes, J. Neurochem. 65, 1342.
4. Buisson, A., I. Margaill, J. Callebert, M. Plotkine and R.G. Boulu, 1993, Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia, J. Neurochem. 690.
5. Bullock, R., D.I. Graham, S. Swanson and J. McCulloch, 1990, Neuroprotective effect of the AMPA receptor antagonist LY 293558 in focal ischemia in the cat, J. Cereb. Blood Flow Metab. 14, 466.
6. G-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neurodegeneration in the gerbil, Eur. J. Pharmacol. 260, 191.
7. G-Nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia, Eur. J. Pharmacol. 285, 203.
8. Choi, D.W., 1993, Nitric oxide: foe or friend to the injured brain?, Proc. Natl. Acad. Sci. USA 90, 9741.
9. Crain, B.J., W.D. Westerkam, A.H. Harrison and J.V. Nadler, 1988, Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: a silver impregnation study, Neuroscience 27, 387.
10. Dalkara, T., T. Yoshida, K. Irikura and M.A. Moskowitz, 1994, Dual role of nitric oxide in focal cerebral ischemia, Neuropharmacology 33, 1447.
11. Dawson, D.A., K. Kusumoto, D.I. Graham, J. McCulloch and I.M. Macrea, 1992, Inhibition of nitric oxide synthase does not reduce infarct volume in a rat model of focal cerebral ischaemia, Neurosci. Lett. 142, 151.
12. Dawson, D.A., D.I. Graham, J. McCulloch and I.M. Macrae, 1994, Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia, Br. J. Pharmacol. 113, 247.
13. Dawson, D.A., 1995, Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcomes, Cerebrovasc. Brain Metab. Rev. 6, 299.
14. G-nitro arginine in brain in vitro and in vivo, Biochem. Biophys. Res. Commun. 176, 1136.
15. Garthwaite, J., G. Garthwaite, R.M.J. Palmer and S. Moncada, 1989, NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices, Eur. J. Pharmacol. 172, 413.
16. Ginsberg, M.D. and R. Busto, 1989, Rodent models of cerebral ischemia, Stroke 20, 1627.
17. Hewett, A.J., C.A. Csernansky and D.W. Choi, 1994, Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS, Neuron 13, 487.
18. Huang, Z., P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman and M.A. Moskowitz, 1994, Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science 265, 1883.
19. Iadecola, C., F. Zhang, S. Xu, R. Casey and M.E. Ross, 1995, Inducible nitric oxide synthase (iNOS) gene expression contributes to cerebral ischemic damage: a novel approach to stroke treatment using and iNOS inhibitor, Ann. Neurol. 38, S286.
20. Kirino, T., 1982, Delayed neuronal death in the gerbil hippocampus following ischemia, Brain Res. 1, 494.
21. Kohno, K., S. Ohta, S. Furuta, K. Kohno, Y. Kumon and S. Sakaki, 1995, Intraventricular administration of nitric oxide synthase inhibitors prevents delayed neuronal death in gerbil hippocampal CA1 neurons, Neurosci. Lett. 199, 65.
22. McCulloch, J., 1992, Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man, Br. J. Clin. Pharmacol. 34, 106.
23. Meldrum, B. and J. Garthwaite, 1990, Excitatory amino acids in neurotoxicity and neurodegenerative diseases, Trends Pharmacol. Sci. 11, 379.
24. Moncada, S., R.M.J. Plamer and E.A. Higgs, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev. 43, 109.
25. G-Nitro arginine methyl ester exhibits anti-nociceptive activity in the mouse, Br. J. Pharmacol. 102, 198.
26. Moore, P.K., R.C. Babbedge, P. Wallace, Z.A. Gaffen and S.L. Hart, 1993a, 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without incresaing blood pressure, Br. J. Pharmacol. 108, 296.
27. Moore, P.K., P. Wallace, Z. Gaffen, S.L. Hart and R.C. Babbedge, 1993b, Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects, Br. J. Pharmacol. 110, 219.
28. Nagafuji, T., M. Sugiyama, A. Muto, T. Makino, T. Miyauchi and H. Nabata, 1995a, The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia, NeuroReort 6, 1541.
29. Nagafuji, T., M. Sugiyama, T. Matsui, A. Muto and S. Naito, 1995b, Nitric oxide synthase in cerebral ischemia, Mol. Chem. Neuropathol. 26, 107.
30. Niiro, M., K. Kadota, T. Asakura, K. Yatsushiro and H. Noguchi, 1995, Changes in nitric oxide generation in rats with global ischemia - in vivo measurement using a nitric oxide sensor, Neurosci. Jpn. 21, 143.
31. Nowicki, J.P., D. Duval, H. Poignet and B. Scatton, 1991, Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse, Eur. J. Pharmacol. 204, 339.
32. O'Neill, M., M. Caldwell, B. Earley, M. Canney, A. O'Halloran, J. Kelly, B.E Leonard and J.-L. Junien, 1995a, The σ receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia, Eur. J. Pharmacol. 283, 217.
33. O'Neill, M., H. Allain, D. Bentué-Ferrer, E. Bellissant, J. de Certaines and B.E. Leonard, 1995b, Pharmacological strategies in the treatment of cerebral ischemia, Eur. Neurol. 3 (Suppl. 1) 28.
34. G-nitro-L-argine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats, Brain Res. 677, 204.
35. Schulz, J.B., R.T. Mattehews, M.M.K. Muqit, S.E. Browne and M. Flint Beal, 1995, Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice, J. Neurochem. 64, 936.
36. Sheardown, M.J., E.O. Nielson, A.J. Hansen, P. Jacobsen and T. Honoré, 1990, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia, Science 247, 571.
37. Siesjö, B.K., 1992a, Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology, J. Neurosurg. 77, 337.
38. Siesjö, B.K., 1992b, Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms and drug treatment, J. Neurosurg. 77, 1247.
39. Szabó, C., G.J. Southan and C. Thiemermann, 1994, Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase, Proc. Natl. Acad. Sci. USA 91, 12472.
40. Traystman, R.J., J.R. Kirsch and R.C Koehler, 1991, Oxygen radical mechanisms of brain injury following ischemia and reperfusion, J. App. Physiol. 71, 1185.
41. G-Nitro-L-arginine enhances neuronal death following ischemia in gerbils, Neurosci. Lett. 146, 251.
42. Yamamoto, S., E.V. Golanov, S.B. Berger and D.J. Reis, 1992, Inhibition of nitric oxide synthesis increases focal ischaemic infarction in rat, J. Cereb. Blood Flow Metab. 11, S2, S288.
43. Yoshida, T., T. Dalkara, K. Irikura and M.A. Moskowitz, 1994a, Inhibition of neuronal nitric oxide production by 7-nitro-indazole decreases infarct size in focal cerebral ischemia, in: Pharmacology of Cerebral Ischemia 1994, eds. J. Kriegstein and H. Oberpichler-Schwenk (Medpharm Scientific Publishers, Stuttgart) p. 329.
44. Yoshida, T., V. Limmroth, K. Irikura and M.A. Moskowitz, 1994b, The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the reponse to topical acetylcholine in pial vessels, J. Cereb. Blood Flow Metab. 14, 924.
45. Yoshida, T., C. Waeber, Z. Huang and M.A. Moskowitz, 1995, Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion, Neurosci. Lett. 194, 214.
46. Zhang, F., R.M. Casey, M.E. Ross and C. Iadecola, 1996, Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion, Stroke 27, 317.